Clinical Trial Update: Sunitinib Before and After Surgery in Treating Patients With Stage IV Kidney Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating sunitinib given before and after surgery in patients with stage IV kidney cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Sutent (sunitinib)

Snippet

Sponsor: Abramson Cancer Center at Penn Medicine | Conditions: Kidney Cancer | Phase 2 | Status: UNKNOWN